Baseline characteristics and interim (3-month) efficacy and safety data from STELLA-LONG TERM, a long-term post-marketing surveillance study of ipragliflozin in Japanese patients with type 2 diabetes in real-world clinical practice

Maegawa Hiroshi; Tobe Kazuyuki; Tabuchi Hiromi; Nakamura Ichiro

首页> 外文期刊>Expert opinion on pharmacotherapy >Baseline characteristics and interim (3-month) efficacy and safety data from STELLA-LONG TERM, a long-term post-marketing surveillance study of ipragliflozin in Japanese patients with type 2 diabetes in real-world clinical practice

【24h】

Baseline characteristics and interim (3-month) efficacy and safety data from STELLA-LONG TERM, a long-term post-marketing surveillance study of ipragliflozin in Japanese patients with type 2 diabetes in real-world clinical practice

机译：来自STELLA-LONG TERM的基线特征以及中期（3个月）有效性和安全性数据，这是ipragliozozin在日本2型糖尿病患者中的实时售后长期监测研究，在现实世界中是临床实践

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: To evaluate the efficacy and safety of ipragliflozin in real-world clinical practice in Japanese patients with type 2 diabetes.

机译：目的：评估依普列净在日本2型糖尿病患者的临床实践中的疗效和安全性。

著录项

来源
《Expert opinion on pharmacotherapy》 |2016年第15期|共10页
作者
Maegawa Hiroshi; Tobe Kazuyuki; Tabuchi Hiromi; Nakamura Ichiro;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词
Ipragliflozin; Japan; post-marketing surveillance; safety; sodium-glucose cotransporter 2 inhibitor; type 2 diabetes;

机译：依帕列净;日本;上市后监测;安全性;钠-葡萄糖共转运蛋白2抑制剂;2型糖尿病;

相似文献

外文文献
中文文献

1. Baseline characteristics and interim (3-month) efficacy and safety data from STELLA-LONG TERM, a long-term post-marketing surveillance study of ipragliflozin in Japanese patients with type 2 diabetes in real-world clinical practice [J] . Maegawa Hiroshi, Tobe Kazuyuki, Tabuchi Hiromi, Expert opinion on pharmacotherapy . 2016,第15期

机译：来自STELLA-LONG TERM的基线特征以及中期（3个月）有效性和安全性数据，这是ipragliozozin在日本2型糖尿病患者中的实时售后长期监测研究，在现实世界中是临床实践
2. Safety and Effectiveness of Ipragliflozin for Type 2 Diabetes in Japan: 12-Month Interim Results of the STELLA-LONG TERM Post-Marketing Surveillance Study [J] . Nakamura Ichiro, Maegawa Hiroshi, Tobe Kazuyuki, Advances in therapy. . 2019,第4期

机译：日本2型糖尿病Ipragliflozin的安全性和有效性：12个月的史黛拉长期营销后监测研究的临时结果
3. Effect of ipragliflozin on liver function in Japanese type 2 diabetes mellitus patients: a subgroup analysis of the STELLA-LONG TERM study (3-month interim results) [J] . Hiromi Tabuchi, Hiroshi Maegawa, Kazuyuki Tobe, Endocrine journal . 2019,第1期

机译：依普列净对日本2型糖尿病患者肝功能的影响：STELLA-LONG TERM研究的亚组分析（3个月的中期结果）
4. IMANI-1 TC3WP Single Drug HAART -Proof of Concept Study Pilot Study of the Safety and Efficacy of Kaletra (LPV/r) as Single Drug HAART in HIV+ ARV- Naive Patients - Interim Analysis of Subjects Completing Final 48 Week Data [C] . J.C. Gathe Jr., M. Washington, C. Mayberry International AIDS Conference . 2004

机译：Imani-1 TC3WP单药搭载概念研究试验试验研究Kaletra（LPV / R）作为艾滋病毒+ ARV天真患者单药HAART的安全性和有效性 - 临时分析受试者完成最终的48周数据
5. A study of the effects of learning and practicing the Radiance TechniqueRTM (authentic ReikiRTM) on the quality of life of people living with type 2 diabetes and on long-term practitioners. [D] . Prone, Denis John. 2002

机译：关于学习和练习Radiance TechniqueRTM（真实的ReikiRTM）对2型糖尿病患者和长期从业者的生活质量的影响的研究。
6. Impact of body mass index on the efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes mellitus: A subgroup analysis of 3‐month interim results from the Specified Drug Use Results Survey of Ipragliflozin Treatment in Type 2 Diabetic Patients: Long‐term Use study [O] . Kazuyuki Tobe, Hiroshi Maegawa, Hiromi Tabuchi, 2019

机译：体重指数对日本2型糖尿病患者依普列净疗效和安全性的影响：依普列净治疗2型糖尿病患者特定药物使用结果调查的3个月中期结果的亚组分析：长期使用研究
7. Safety and efficacy of ipragliflozin in Japanese patients with type 2 diabetes in real-world clinical practice: interim results of the STELLA-LONG TERM post-marketing surveillance study [O] . Ichiro Nakamura, Hiroshi Maegawa, Kazuyuki Tobe, 2017

机译：在现实世界临床实践中患者2型糖尿病患者Ipragliflozin的安全性和有效性：史黛拉长期营销后监测研究中的临时结果

Baseline characteristics and interim (3-month) efficacy and safety data from STELLA-LONG TERM, a long-term post-marketing surveillance study of ipragliflozin in Japanese patients with type 2 diabetes in real-world clinical practice

摘要

著录项

相似文献

相关主题

期刊订阅